Common clinical indications

• Cystic fibrosis in patients with at least one F508del CFTR mutation (age ≥6 years per labeling in this formulary text)

Frequently asked questions

What is Elexacaftor/Tezacaftor/Ivacaftor used for?

Elexacaftor/Tezacaftor/Ivacaftor (Elexacaftor/Tezacaftor/Ivacaftor) is listed in YMed Atlas under Cystic fibrosis therapy. Indications, dosing, and safety information on this page summarize curated references—always confirm with current labeling, formularies, and local protocols.

How do I adjust dosing for renal impairment or special populations?

Review the dosing sections and references for this monograph. Many agents require renal or hepatic adjustment; pediatric, pregnancy, and lactation considerations are clinician-specific. This interface is educational and does not replace individualized prescribing decisions.

Is this medical advice?

No. YMed Atlas drug pages support learning and quick reference. They are not a substitute for clinical judgment, pharmacist review, or formal interaction checking with a complete medication list.